In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Marathon Biopharmaceuticals Inc.

Division of Lonza Group Ltd.
www.marathonbio.com

Latest From Marathon Biopharmaceuticals Inc.

US Insulin Pricing Probe Clouds Prospects for Novo Nordisk, Others

As US prosecutors investigate Novo Nordisk and other insulin makers for their pricing and contracts with pharmacy benefit managers, plaintiff firms allege the Danish group engaged in collusive agreements and misled investors about its earnings and forecasts.

BioPharmaceutical Policy

Insulin Pricing, PBM Relationships Under Government Microscope

Minnesota Attorney General demands Novo Nordisk and Sanofi provide information on their insulin pricing; they are also among several companies facing probes over their contracts with pharmacy benefit managers.

Pharmacy Benefit Management Pricing Debate

Allergan Exits Noctiva Partnership With Serenity Just As FDA Approves Controversial Drug

Just as Noctiva obtains FDA approval as the first drug for nocturia due to nocturnal polyuria, Allergan bails on collaboration signed seven years ago.

Approvals Deals

Tech Transfer Roundup: Aduro Hopes Stanford Algorithm Will Optimize Its IO Candidates

Aduro Biotech discusses what it looks for in an academic collaboration. Plus, Sarepta adds gene therapies to its Duchenne pipeline from Nationwide Children's Hospital and Columbia University out-licenses IP to a pair of biotechs.

Deals StartUps and SMEs
See All

Company Information

UsernamePublicRestriction

Register